Capitolis Advisors’s CME Group CME Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-300,568
Closed -$68.7M 215
2021
Q4
$68.7M Sell
300,568
-17,690
-6% -$3.89M 0.41% 57
2021
Q3
$68.1M Buy
318,258
+13,480
+4% +$2.73M 0.62% 43
2021
Q2
$64.8M Buy
304,778
+269,938
+775% +$57M 0.76% 32
2021
Q1
$7.12M Sell
34,840
-23,538
-40% -$4.64M 0.12% 149
2020
Q4
$10.6M Buy
+58,378
New +$9.93M 0.18% 127

Other funds holding CME

Capitolis Advisors's CME Position: Q1 2022 in Review

Capitolis Advisors sold out of CME Group (CME) in Q1 2022, closing a stake of 300,568 shares — an estimated $68.7M sold.

Capitolis Advisors first reported a position in CME in Q4 2020 and held it in 5 quarters. The position peaked at $68.7M in Q4 2021. 1,183 funds tracked by Wall St. Rank hold CME as of Q1 2022.

  • Capitolis Advisors reported no remaining CME Group position as of Q1 2022 after selling out during the quarter.
  • Capitolis Advisors sold 300,568 CME Group shares in Q1 2022, an estimated $68.7M.
  • Capitolis Advisors first reported a position in CME Group in Q4 2020 and held it in 5 quarters.
  • Capitolis Advisors's CME Group position peaked at $68.7M in Q4 2021.
  • 1,183 funds tracked by Wall St. Rank held CME Group as of Q1 2022.

Based on Capitolis Advisors's 13F filing for Q1 2022, filed 12 May 2022.